直接口服抗凝剂测定利用和相关出血事件:一个多中心队列研究
Brandon Stretton1,2,3, Joshua Kovoor1,2,3, Stephen Bacchi1,3,4
1Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, Australia.
Hospital practice (1995)
|November 28, 2024
概括
在患有出血事件的患者中,直接口服抗凝剂 (DOAC) 的水平差异很大. 较高的DOAC血度与出血严重程度无关,但与增加的抗凝剂逆向注射有关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 血液学 血液学 血液学
背景情况:
- 关于直接口服抗凝剂 (DOAC) 测定血度及其与出血事件或输血需求的关联的证据有限.
- 了解这些关联对于治疗出血的抗凝血药患者至关重要.
研究的目的:
- 在紧急出血患者中描述DOAC分析的使用和血水平.
- 调查DOAC血水平与出血严重程度之间的关联.
主要方法:
- 一个多中心的回顾性队列研究,包括86名患有紧急出血和DOAC检测的患者.
- 分析包括线性和二进制物流回归来评估结果.
主要成果:
- 中位数DOAC测定血水平为122.9 ng/ml,测定后平均4.8小时进行测定.
- DOAC 血水平与出血类型或严重程度没有显著关联.
- 每增加10个单位/毫升的DOAC测定血水平与反凝剂逆向注射的几率增加4%相关.
结论:
- 在出血患者中,DOACs的血水平呈现出广泛的范围.
- 较高的DOAC血水平并不预示出更糟糕的出血结果或增加的输血需求.
- 较高的DOAC血水平与给予逆转药物的可能性更高有关.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Disorders of Hemostasis
710
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
710


